By Liz Richardson
The COVID-19 quarantine changed everyday life for Americans, including many aspects of our diet, health and exercise regimens. There’s one change that has not received enough scrutiny: During the pandemic, millions of Americans turned to dietary supplements.
In 2020, dietary supplement sales were 14.5% higher than the previous year. That’s the largest growth spurt since 1997, according to a 2021 report from the Nutrition Business Journal on supplement sales.
Today, nearly three-quarters of U.S. consumers take regular doses of vitamins, fish oil, herbs and similar products, the Council for Responsible Nutrition reports. The Food and Drug Administration is tasked with overseeing the booming supplement industry, but the agency has less insight and exerts far less oversight than many Americans want and expect.
A national survey conducted for The Pew Charitable Trusts showed about half of adults overestimate the regulatory scrutiny dietary supplements receive. The reality is the FDA doesn’t know for certain what products are on the market or what’s in them.
People are also reading…
This is a serious challenge — one Congress can address by passing Senate Bill 4090. The Dietary Supplement Listing Act of 2022 was recently introduced by Sen. Dick Durbin, D-Ill., and co-sponsored by Sen. Mike Braun, R-Ind.
The FDA’s lack of insight stems from a gap in a 1994 law that put the agency in charge, and in a reactive stance, of supplement safety. The agency scans the internet and evaluates reports from consumers, doctors and companies for signs of products that put people’s health at risk or already have done harm.
However, for such post-market oversight to work, regulators need accurate, timely data about products being sold. They don’t have it because current law doesn’t require supplement manufacturers to provide the FDA with the most basic information, including product names, ingredients and directions for use.
The potential risks have grown exponentially over the past 25 years. When Congress first gave the FDA responsibility for supplements, there were about 4,000 on the market, generating about $4 billion a year in sales. The FDA now believes there could be as many as 80,000 products, netting more than $40 billion annually.
Many, if not most, supplements are well known to consumers and have a well-documented safety record. However, from 2007 to 2019, the FDA found almost 1,000 products masquerading as dietary supplements.
These products actually contained active and potentially harmful pharmaceutical compounds from prescription drugs. The most common ones were erectile dysfunction treatments, steroids and weight loss drugs — including one removed from the market in 2010 because it significantly increased risk of heart attack and stroke.
The FDA cautioned that in 12 years of data studied, the agency likely identified only “a small fraction of the potentially hazardous products with hidden ingredients.” Durbin and Braun’s legislation would require supplement manufacturers to provide a comprehensive list of each product’s ingredients, the amount of each ingredient, warnings and precautions about the product, and allergen statements, among other information.
These lists would help the agency quickly and efficiently identify potentially dangerous products and remove them from the market. The FDA also would provide the data in a searchable public database for consumers and others to use to make more informed decisions.
Industry leaders, medical societies, and public health and consumer advocates strongly support the legislation. They have worked together to help policymakers develop an effective and pragmatic proposal.
There is bipartisan support on Capitol Hill, and the public wants action. In Pew’s survey, when consumers were informed the FDA did not review or approve dietary supplements before they hit the market, 71% of respondents said they believed the agency was unable to keep consumers safe. Nearly all (95%) supported requiring manufacturers to report their products and ingredients to the FDA.
The Dietary Supplement Listing Act would allow the FDA to shine a light on dietary supplements and empower the agency to act quickly to protect consumers when threats arise. It would help consumers make informed decisions about how to stay well. And it would help the supplement industry by leveling the playing field for responsible manufacturers and preserving consumer confidence.
Congress should quickly pass this important legislation to ensure the FDA has the tools to fully protect consumers who use dietary supplements.
Liz Richardson directs The Pew Charitable Trusts’ health care products project, which focuses on strengthening and improving medical product regulation to safeguard patients and consumers.
© 2022, Chicago Tribune
Distributed by Tribune Content Agency
#lee-rev-content { margin:0 -5px; } #lee-rev-content h3 { font-family: inherit!important; font-weight: 700!important; border-left: 8px solid var(–lee-blox-link-color); text-indent: 7px; font-size: 24px!important; line-height: 24px; } #lee-rev-content .rc-provider { font-family: inherit!important; } #lee-rev-content h4 { line-height: 24px!important; font-family: “serif-ds”,Times,”Times New Roman”,serif!important; margin-top: 10px!important; } @media (max-width: 991px) { #lee-rev-content h3 { font-size: 18px!important; line-height: 18px; } }
from WordPress https://ift.tt/lTNcCGf
via IFTTT
No comments:
Post a Comment